Posted in Clinical Data AZ claims another win for Imfinzi in frontline liver cancer April 2, 2026 Pharmaphorum AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme. Clinical DataOncologyRead full story